GYRE Competitors & Alternatives
Compare Gyre Therapeutics Inc. with similar stocks in the same industry
Biotechnology
GYRE
Main Stock$5.86
Tradestie Score
52
Market Cap
$688.47M
Revenue Growth
0.0%
Analyst Upside
+218.5%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 51 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$126.39
|
$699.30M | - | 68 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 49 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$9.77
|
$665.30M | 11.3 | 57 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$14.04
|
$626.91M | - | 45 | Compare |
|
SVRA
Savara Inc.
|
$4.54
|
$611.84M | - | 68 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 49 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$2.44
|
$552.46M | - | 66 | Compare |
|
VSTM
Verastem, Inc.
|
$10.06
|
$541.60M | - | 44 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$10.65
|
$540.97M | - | 57 | Compare |
More GYRE Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry